Dustin Moore is a researcher and analyst focusing on overlooked and undervalued investments. He enjoys analyzing under-the-radar companies with massive upside potential and those with favorable risk/reward ratios. On Twitter! @dustinrmoore https://twitter.com/dustinrmoore
Netherlands based non-professional stocktrader with a private portfolio; good at stockpicking; not good at options. I prefer companies with a good ROI, ROE, PEG-ratio, good and inspiring management, a durable competative advantage. BUY AND ACCUMULATE (B&A) is my approach. I'm in the market for the company's profit, not the stockprice in the first place.
Catalyst Global is a New York-based capital markets consultancy. We post investments we like - including clients, client prospects and companies we do not work with. Our posts are not vetted or approved by our clients.
I use value investing methods of analysis to search out undervalued companies using a combination of financial analysis and a qualitative assessment of management, industry & company fundamentals and circumstances to evaluate the odds of a successful investment. Emphasis is currently on consumer non-durables with strong brands and market shares, but there is no limit to such investments only. Past investments have included oil companies, consumer retail and consumer durables.
----->Top Idea #1: Zooplus, publ. Oct. 24th 2014, return since: +116.3%
----->Top Idea #2: Coca-Cola Bottling Co., publ. May 20th 2015, return: +72%
(calculated as of Sept 30th 2015)
I try to generate a couple of high probability ideas (2-3) every year and take very concentrated positions based on those ideas. Over the past 8 years this strategy has generated a 22,87% compounded average return net of all costs and taxes on my investment portfolio, with the strongest returns mostly during the past five years.
Current sectors under coverage by me at Seeking Alpha:
-personal & household goods
Disclaimer: all investment analyses and information written and published by me, as well as all comments, should not be considered as investment advice or used as such. All readers are strongly urged to perform their own research and due diligence on the equity shares and other investment products I have written about. I have no business or any other forms of relationship with the companies featured in my analyses, unless explicitly stated so in the article disclaimer.
Full disclosure, I am the Vice President of 21Vianet Group, Inc. However, I am not part of the IR team and therefore not in any position to answer any questions or engage in any discussion with any of our investors (or potential investors) on the behalf of my Company.
I am an investor relations consultant with 25+ years experience steering IR strategy and outreach for over 100 companies across a range of industries. We launched Catalyst Global in early 2012 to serve as a platform for innovating the IR role to better address the radically different dynamics and needs of public companies and investors.
Catalyst's mission is combining senior level experience and counsel with targeted outreach and efficient communications to deliver real change and share price results for "smidcap" companies in today's markets. We understand relationships and credibility take time, and we root all our work in integrity, candor and a focus on ROI.
I post on Seeking Alpha to expand the reach of client and other investment stories we like - and to understand the nature of these new channels of communication. Networking ideas and working with new media is integral to the IR function - plus it's fun.
CG Focus List is a separate service we use to highlight specific investment stories brought to us by some of the really smart investors we know. Profiled companies can be clients, ex-clients, non-clients or desired clients - but they are stories that offer very attractive investment potential and commensurate risk (there's no free ride in investing!)
My posts are NOT endorsed by the Companies on which I write - client or otherwise. We believe in truth and fair play at all times, and at all costs, and gravitate to those who share that view.
"If you need a friend in the market, then get a dog...it's trench warfare out there Sport and in here too..."
"The most valuable commodity I know of ... is information."
"Greed, for lack of a better word, is good. Greed is right, greed works. Greed clarifies, cuts through, and captures the essence of the evolutionary spirit..."
"What's worth doing is worth doing for money..."
- Gordon Gekko
"The Art of Speculation, like the Art of War, is all about Preparation.
Especially once the dogs are unleashed." - Get a Dog ... of War
I have written 2 dutch books on value investing: "Aandelen selecteren als waardebelegger" and "Beleggen in bull- en bearmarkten". See bol.com (search for the titles). As a mathematician (Ph.D.) I am most interested in investment strategies with statistically favorable returns. In particular I invest in net-nets (20-30% average annual returns). I find companies with low Enterprise Value/Earnings before Tax and Interest (EV/EBIT) and strong balance sheets (20% average annual returns) also very interesting. Since such stocks are rare I invest globally. Send me a message with your email address to get example articles of my premium research on Seeking Alpha.
I am a professional who spends their day looking at securities, swaps, legislation and legal implications on the same. I look for value where it is otherwise not found. EQUITY, DEBT, CDS, ISDAFIX (IR SWAPS) FX. and a major advocate of good corporate governance = better valuations.
I am an independent trader of equities and options on equities as well as some commodities. I trade over timeframes that make "technical analysis" useless - namely ALL time frames. My trading goal is usually a 5% ROI within a "short" time. Previously to full time markets participation I was a Research Chemist working in the Specialty Chemical Industry. I was/am particularly skilled in Molecular Modeling, Rheology, Data Acquisition and Analysis. I have deep experience in Artificial Neural Networks and Genetic Algorithms. My current focus is in studying and applying non-Normal (Gaussian) price return distributions for modeling Option Premia. I use home-brew code for advanced Time Series Analysis. Trading the "Market" is the hardest way to make "easy" money. In general, I am a Wild And Crazy Guy.
Steven H. Goldman is a commercial litigation lawyer and senior partner in the Toronto law firm of Goldman Hine LLP. He is a former member of the board of directors of Tribute Pharmaceuticals Inc., a Canadian public pharmaceutical company which recently merged with Pozen Pharmaceuticals on February 5, 2016, and is now known as Aralez Pharmaceuticals (Nasdaq: ARLZ). He is currently on the board of directors of both Select Sands Corp. (TSX.V: SNS.V) as well as Comstock Metals Ltd. (TSX.V: CSL.V) which both trade on the TSX Venture exchange.